Medications

More biosimilars marketed in Germany, Switzerland than U.S.

More biosimilars have been marketed in Germany and Switzerland than in the United States, but uptake has increased over time in all countries, according to a study published online Dec. 2 in JAMA Network Open.

page 10 from 40